Article thumbnail

By 

Abstract

Quantitative and qualitative T-cell measurements ex vivo allow to distinguish between spontaneous and vaccine-induced antigen-specific T-cell responses, and a combination thereof. The majority of currently applied tumor vaccines induce T-cell responses in only a fraction of patients, suggesting that patient and disease related factors are co-responsible for T-cell activation. In contrast, the use of CpG oligodeoxynucleotide 7909 as immune adjuvant leads to reproducible ex vivo detectable T-cell responses in all vaccinated patients, enabling for the first time to study immune responses that are dominantly elicited by the vaccine. Spontaneous tumor antigen specific T-cell responses The HLA-A2/Melan-A(MART-1) antigenic system constitutes a well-defined model for studies of CD8+ T-cell responses in humans (1, 2, 3). For all studies, we use a standardized approac

Year: 2016
OAI identifier: oai:CiteSeerX.psu:10.1.1.1002.1025
Provided by: CiteSeerX
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://cancerimmunolres.aacrjo... (external link)
  • http://cancerimmunolres.aacrjo... (external link)
  • http://citeseerx.ist.psu.edu/v... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.